RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Wuhan Hvsen Biotechnology Co - Stock

Wuhan Hvsen Biotechnology Co Net Income 2024

Wuhan Hvsen Biotechnology Co Net Income

98.38 M CNY

Ticker

300871.SZ

ISIN

CNE1000047H6

In 2024, Wuhan Hvsen Biotechnology Co's profit amounted to 98.38 M CNY, a 486.27% increase from the 16.78 M CNY profit recorded in the previous year.

The Wuhan Hvsen Biotechnology Co Net Income history

YEARNET INCOME (undefined CNY)
2026e169.83
2025e171.48
2024e98.38
202316.78
202252.71
2021132.9
2020150.2
201968.8
201871.4
201788.4

Wuhan Hvsen Biotechnology Co Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Wuhan Hvsen Biotechnology Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Wuhan Hvsen Biotechnology Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Wuhan Hvsen Biotechnology Co’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Wuhan Hvsen Biotechnology Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Wuhan Hvsen Biotechnology Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Wuhan Hvsen Biotechnology Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Wuhan Hvsen Biotechnology Co’s growth potential.

Wuhan Hvsen Biotechnology Co Revenue, Profit, and EBIT History

DateWuhan Hvsen Biotechnology Co RevenueWuhan Hvsen Biotechnology Co EBITWuhan Hvsen Biotechnology Co Net Income
2026e1.68 B undefined0 undefined169.83 M undefined
2025e1.51 B undefined0 undefined171.48 M undefined
2024e1.24 B undefined0 undefined98.38 M undefined
20231.02 B undefined13.73 M undefined16.78 M undefined
20221.02 B undefined65.78 M undefined52.71 M undefined
2021996.2 M undefined141.9 M undefined132.9 M undefined
2020777.5 M undefined171.5 M undefined150.2 M undefined
2019427.2 M undefined79.7 M undefined68.8 M undefined
2018421.9 M undefined82.4 M undefined71.4 M undefined
2017399.7 M undefined103.5 M undefined88.4 M undefined

Wuhan Hvsen Biotechnology Co stock margins

The Wuhan Hvsen Biotechnology Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Wuhan Hvsen Biotechnology Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Wuhan Hvsen Biotechnology Co.

  • 3 years

  • 5 years

  • 10 years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Wuhan Hvsen Biotechnology Co's sales revenue. A higher gross margin percentage indicates that the Wuhan Hvsen Biotechnology Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Wuhan Hvsen Biotechnology Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Wuhan Hvsen Biotechnology Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Wuhan Hvsen Biotechnology Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Wuhan Hvsen Biotechnology Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Wuhan Hvsen Biotechnology Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Wuhan Hvsen Biotechnology Co Margin History

Wuhan Hvsen Biotechnology Co Gross marginWuhan Hvsen Biotechnology Co Profit marginWuhan Hvsen Biotechnology Co EBIT marginWuhan Hvsen Biotechnology Co Profit margin
2026e20.66 %0 %10.12 %
2025e20.66 %0 %11.36 %
2024e20.66 %0 %7.95 %
202320.66 %1.35 %1.65 %
202221.82 %6.43 %5.15 %
202127.01 %14.24 %13.34 %
202036.9 %22.06 %19.32 %
201938.09 %18.66 %16.1 %
201843.45 %19.53 %16.92 %
201750.69 %25.89 %22.12 %

Wuhan Hvsen Biotechnology Co Aktienanalyse

What does Wuhan Hvsen Biotechnology Co do?

Wuhan Hvsen Biotechnology Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Wuhan Hvsen Biotechnology Co's Profit Margins

The profit margins of Wuhan Hvsen Biotechnology Co represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Wuhan Hvsen Biotechnology Co's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Wuhan Hvsen Biotechnology Co's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Wuhan Hvsen Biotechnology Co's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Wuhan Hvsen Biotechnology Co’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Wuhan Hvsen Biotechnology Co Stock

How much profit has Wuhan Hvsen Biotechnology Co made this year?

Wuhan Hvsen Biotechnology Co has made 98.38 M CNY this year.

How has the profit developed compared to last year?

The profit has increased by 486.27% compared to last year increased

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Wuhan Hvsen Biotechnology Co publish its earnings?

Wuhan Hvsen Biotechnology Co publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Wuhan Hvsen Biotechnology Co?

The profits of Wuhan Hvsen Biotechnology Co are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Wuhan Hvsen Biotechnology Co?

You can learn more about the earnings of Wuhan Hvsen Biotechnology Co by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Wuhan Hvsen Biotechnology Co pay?

Over the past 12 months, Wuhan Hvsen Biotechnology Co paid a dividend of 0.3 CNY . This corresponds to a dividend yield of about 3.05 %. For the coming 12 months, Wuhan Hvsen Biotechnology Co is expected to pay a dividend of 0.3 CNY.

What is the dividend yield of Wuhan Hvsen Biotechnology Co?

The current dividend yield of Wuhan Hvsen Biotechnology Co is 3.05 %.

When does Wuhan Hvsen Biotechnology Co pay dividends?

Wuhan Hvsen Biotechnology Co pays a quarterly dividend. This is distributed in the months of June, May, July, June.

How secure is the dividend of Wuhan Hvsen Biotechnology Co?

Wuhan Hvsen Biotechnology Co paid dividends every year for the past 6 years.

What is the dividend of Wuhan Hvsen Biotechnology Co?

For the upcoming 12 months, dividends amounting to 0.3 CNY are expected. This corresponds to a dividend yield of 3.07 %.

In which sector is Wuhan Hvsen Biotechnology Co located?

Wuhan Hvsen Biotechnology Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Wuhan Hvsen Biotechnology Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Wuhan Hvsen Biotechnology Co from 5/29/2024 amounting to 0.27 CNY, you needed to have the stock in your portfolio before the ex-date on 5/29/2024.

When did Wuhan Hvsen Biotechnology Co pay the last dividend?

The last dividend was paid out on 5/29/2024.

What was the dividend of Wuhan Hvsen Biotechnology Co in the year 2023?

In the year 2023, Wuhan Hvsen Biotechnology Co distributed 0.331 CNY as dividends.

In which currency does Wuhan Hvsen Biotechnology Co pay out the dividend?

The dividends of Wuhan Hvsen Biotechnology Co are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Wuhan Hvsen Biotechnology Co

Our stock analysis for Wuhan Hvsen Biotechnology Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Wuhan Hvsen Biotechnology Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.